Ervexia Occupational Health vs Complete Mobile Drug Testing
Franchise Comparison 2026
FDDs: Ervexia Occupational Health 2025, Complete Mobile Drug Testing 2026SBA 7(a) data through FY2026Updated How we score
Not like-for-like: these figures come from FDDs of different years (2025, 2026). Costs, fees and unit counts change from one filing to the next, so the older column may be out of date.
Both Ervexia Occupational Health and Complete Mobile Drug Testing are franchises in the healthcare category. Ervexia Occupational Health requires an investment of $99K – $213K while Complete Mobile Drug Testing requires $68K – $288K. Complete Mobile Drug Testing discloses average gross sales of $889K; no Item 19 gross sales figure is on file for Ervexia Occupational Health. Note: Company-owned outlets only - not franchisee performance; Based on a single outlet - not a system average. FranchiseVerdict rates Ervexia Occupational Health C (Middle tier) and Complete Mobile Drug Testing B (Second tier).
| Metric | Ervexia Occupational Health | Complete Mobile Drug Testing |
|---|---|---|
| Verdict Grade | ||
| Investment Range | $99K – $213K | $68K – $288K |
| Franchise Fee | $45K | $55K |
| Royalty Rate | 8.0% | 10.0% |
| Average Gross Sales (Item 19) | N/AIncl. company outlets | $889KCompany-owned only · n=1 |
| SBA Charge-Off Rate | N/A | N/A |
| Total Units | 3 | 1 |
| Unit Growth (YoY) | -1 units | +0 units |
| Year Began Franchising | 2024 | 2025 |
| FDD Year | 2025 | 2026 |
Next step
Browse free
Every brand with an FDD on file, graded, with costs, disclosed sales and SBA records. No sign-in.Pro
For advisors and lenders working across many brands; inquire by email.